Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,099 GBX | -0.55% | -2.20% | +14.13% |
05-16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
05-16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.13% | 239B | |
+31.89% | 694B | |
+29.22% | 593B | |
-1.63% | 371B | |
+19.72% | 331B | |
+6.64% | 290B | |
-2.94% | 209B | |
+10.00% | 209B | |
+8.13% | 169B | |
-0.42% | 164B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : JP Morgan keeps its Buy rating